Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: The Comparison Between M-E-BCS and C-O-BCS. [NA]
This entry notes a planned clinical trial comparing two breast-conserving surgery approaches (M-E-BCS and C-O-BCS) for breast cancer. Recrui…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study
A long-running breast imaging study for women at high genetic risk of breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening [NA]
Completed study comparing Restriction Spectrum Imaging (RSI) to conventional and abbreviated breast MRI for breast cancer screening; results…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) [Phase 3]
Clinical trial update: phase 3 study of tersolisib (LY4064809/STX-478) in combination with other anti-cancer therapies for advanced breast c…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: SENOVIE France - Therapeutic Mobility and Breast Cancer
A completed clinical trial in France (SENOVIE) investigating therapeutic mobility and breast cancer; sponsor is Institut de Recherche pour l…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial to determine the optimal dose of BNT323 in combination with BNT327 for advanced breast cancer, currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors [Phase 1, Phase 2]
Novartis' ECI830 is being studied as a single agent or in combination in adults with advanced HR+/HER2- breast cancer and other advanced sol…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: The PREDICT Registry:
A PREDICT Registry study sponsored by PreludeDx is recruiting to collect data on ductal carcinoma in situ (Stage 0 breast cancer).
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment
A completed clinical trial evaluating cancer outcomes in patients treated with dapagliflozin in addition to other antidiabetic therapies.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating high-dose radiation therapy with pembrolizumab and chemotherapy in PD-L1–positive metastatic triple-negative breast…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer [Phase 2]
A Phase 2 trial is evaluating adding an individualized cancer vaccine to durvalumab, tremelimumab, and chemotherapy in patients with metasta…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating orally administered MOMA-313 in adults with advanced or metastatic solid tumors; the study is currently active but …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) [Phase 3]
A Phase 3 study of sacituzumab govitecan (Sac-TMT, MK-2870) for breast cancer is currently recruiting. The trial includes patients with trip…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Factors Associated With Breast Cancer Risks and Outcomes
A Memorial Sloan Kettering Cancer Center study examining factors associated with breast cancer risk and outcomes. The trial is currently rec…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival [Phase 4]
Phase 4 study that develops and validates a prognostic score to identify metastatic breast cancer patients who are most likely to benefit fr…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity [Phase 2]
A Phase 2 clinical trial from Tanta University is evaluating whether dapagliflozin can prevent doxorubicin-induced cardiotoxicity in breast …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer [Phase 3]
Phase 3 clinical study evaluating adjuvant therapy with TQB3616 plus endocrine therapy versus placebo plus endocrine therapy in breast cance…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial [Phase 2]
Phase 2 clinical trial (DOROTHY) evaluating dose-reduced docetaxel with cyclophosphamide for vulnerable older women with Stage I-III HER2-ne…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET [Phase 2]
This clinical trial update describes a Phase 2 study evaluating detection and outcomes using novel F-18 FAP PET imaging in metastatic invasi…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of LY4337713 in Participants With FAP-Positive Solid Tumors [Phase 1]
A Phase 1 clinical trial update for LY4337713 in participants with FAP-positive solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients [Phase 3]
A Phase 3 clinical trial called ECLECTIC, evaluating EstroTEP and circulating biomarkers for ER-positive, HER2-negative metastatic breast ca…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors [Phase 2]
A Phase 2 clinical trial (EPIC) evaluating enhanced pain coping strategies to manage treatment-related joint pain in breast cancer survivors…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment
A clinical trial investigating quality of life in breast cancer survivors who were pregnant during their treatment has been terminated.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer [Phase 1]
Phase 1 clinical trial update for CF33-hNIS-antiPDL1 in metastatic triple-negative breast cancer shows the study is currently ACTIVE_NOT_REC…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Cancer Survivors Program [NA]
A cancer survivors program trial sponsored by Masaryk Memorial Cancer Institute is currently recruiting and involves prostate and breast can…